NASHVILLE, Tenn.--(BUSINESS WIRE)--Sarah Cannon Research Institute (SCRI) announced today the acquisition of Clinical Development Group (CDG), a strategic clinical trial consulting firm based in New Haven, CT. By joining SCRI, CDG provides expanded capabilities in global clinical and regulatory planning, trial project management, as well as access to therapeutic expertise, key opinion leadership and academic relationships.
Help employers find you! Check out all the jobs and post your resume.
